TY - JOUR
T1 - Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics
AU - Matos, Marliette R.
AU - Ho, Seok Man
AU - Schrode, Nadine
AU - Brennand, Kristen J.
N1 - Funding Information:
This work was partially supported by National Institutes of Health (NIH) grants R56 MH101454 (K.J.B), R01 MH106056 (K.J.B.) and R01 MH109897 (K.J.B.).
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/9
Y1 - 2020/9
N2 - Neuropsychiatric disorders are highly heritable polygenic disorders arising from the complex interplay of highly penetrant rare variants and common variants of small effect. There is a large index of comorbidity and shared genetic risk between disorders, reflecting the pleiotropy of individual variants as well as predicted downstream pathway-level convergence. Importantly, the mechanism(s) through which psychiatric disease-associated variants interact to contribute to disease risk remains unknown. Human induced pluripotent stem cell (hiPSC)-based models are increasingly useful for the systematic study of the complex genetics associated with brain diseases, particularly when combined with CRISPR-mediated genomic engineering, which together facilitate isogenic comparisons of defined neuronal cell types. In this review, we discuss the latest CRISPR technologies and consider how they can be successfully applied to the functional characterization of the growing list genetic variants linked to psychiatric disease.
AB - Neuropsychiatric disorders are highly heritable polygenic disorders arising from the complex interplay of highly penetrant rare variants and common variants of small effect. There is a large index of comorbidity and shared genetic risk between disorders, reflecting the pleiotropy of individual variants as well as predicted downstream pathway-level convergence. Importantly, the mechanism(s) through which psychiatric disease-associated variants interact to contribute to disease risk remains unknown. Human induced pluripotent stem cell (hiPSC)-based models are increasingly useful for the systematic study of the complex genetics associated with brain diseases, particularly when combined with CRISPR-mediated genomic engineering, which together facilitate isogenic comparisons of defined neuronal cell types. In this review, we discuss the latest CRISPR technologies and consider how they can be successfully applied to the functional characterization of the growing list genetic variants linked to psychiatric disease.
KW - CRISPR
KW - Human induced pluripotent stem cell
KW - Psychiatric genetics
UR - http://www.scopus.com/inward/record.url?scp=85088781449&partnerID=8YFLogxK
U2 - 10.1016/j.mcn.2020.103532
DO - 10.1016/j.mcn.2020.103532
M3 - Review article
C2 - 32712198
AN - SCOPUS:85088781449
SN - 1044-7431
VL - 107
JO - Molecular and Cellular Neurosciences
JF - Molecular and Cellular Neurosciences
M1 - 103532
ER -